基于HPMCP包覆介孔SBA-15的pH敏感药物缓释系统

以肠溶性包衣材料羟丙甲纤维素邻苯二甲酸酯(HPMCP)为原料,在负载法莫替丁(Famo)的SBA-15药片表面包覆聚合物膜,成功制备了一种新型的pH敏感药物缓释系统, 并考察了此缓释系统在不同pH释放环境中的释放行为. 结果表明: 在模拟胃液中(SGF, pH=1.2),HPMCP能致密包覆在药片表面,从而明显延缓Famo的释放速度;而在模拟肠液中(SIF, pH=7.5),HPMCP能够迅速溶于缓释溶液中,因而对Famo释放速度的影响甚微. 因此,可以将这种新型智能药物缓释系统应用于肠道靶向给药.     

丝素蛋白膜上5-氟尿嘧啶的包埋及其释放

讨论了包埋在丝素膜中的５－氟脲嘧啶（５－ＦＵ）的固定状况,在不同ＰＨ值下测定了丝素５－ＦＵ复合膜中药物的释放,实验结果表明：５－ＦＵ均匀地被包埋在丝素膜中,即丝素膜可以作为５－ＦＵ载体,经过比涂层保护,丝素５－ＦＵ复合膜中的５－ＦＵ溶解释放速率变慢,释放时间延长;经涂层的 素５－ＦＵ复合膜在接近丝素蛋白等电点（ＰＨ＝４．５）时,５－ＦＵ在溶液中释放速度较慢,释放时间较长,表明用调节外部溶液ＰＨ值的     

微波辅助下5-氟尿嘧啶-1-基乙酸的绿色合成

在微波辐射下,以水作溶剂,以氯乙酸、5-氟尿嘧啶为原料合成了具有重要生理活性的标题化合物5-氟尿嘧啶1-基乙酸．产率86．8％．该方法反应时间短,分离方便,产品纯度高．     

聚羟乙谷氨酰胺-5-氟尿嘧啶-1-乙酸的合成、表征与缓释性

聚羟乙谷氨酰胺-5-氟尿嘧啶-1-乙酸的合成、表征与缓释性;高分子前药     

药物在pH敏感聚甲基丙烯酸-poloxamer水凝胶中的扩散行为

平衡溶胀率;药物扩散;药物在pH敏感聚甲基丙烯酸-poloxamer水凝胶中的扩散行为     

环糊精基的金属有机骨架的合成及负载5-氟尿嘧啶的研究

用溶剂热法合成了基于环糊精的金属有机骨架化合物(Na-CD-MOF),采用X-射线单晶衍射、红外光谱和元素分析进行了结构表征.以5-氟尿嘧啶(5-FU)为模型药物,研究了Na-CD-MOF的细胞毒性和载药及体外释药的能力.研究结果表明,新合成的Na-CD-MOF对5-FU的负载量最大为1.18g/g,且具有明显的缓释作用.体外细胞毒性实验表明,Na-CD-MOF具有良好的生物相容性,有望成为一种绿色的药物载体.     

新型5-氟尿嘧啶-吲哚菁染料偶合物的合成

以抗癌药5-氟尿嘧啶和近红外荧光探针IR780和IR783为原料,经取代、乙酸化和酰胺化反应合成了两种新型的双效抗肿瘤药物5-FU-780和5-FU-783,其结构经¹H NMR, ¹³C NMR, IR和HR-MS表征。     

侧链含5-氟尿嘧啶甲壳胺的合成及其抗肿瘤活性的研究

本文报道了以不同分子量的甲壳胺为载体,制备了侧链含5-氟尿嘧啶的一系列高分子载体药物;通过定氮分析测定了H_2N-基的反应率;由IR、UV和~(13)C-NMR确定了载体药物的结构;模拟生理条件考查了在不同pH的缓冲溶液中5-氟脲嘧啶或其衍生物的水解释放率。体外初步实验结果表明,具有Ⅰ和Ⅱ结构的载体药物对艾氏腹水癌细胞有较强的杀伤作用。     

5-氟尿嘧啶-聚[N-(2-羟乙基)-L-谷酰胺]的合成及缓释性能研究

以聚谷氨酸苄酯为原料,用乙醇胺进行胺解得水溶性的可生物降解的聚[N-(2-羟乙基)-L-谷酰胺];用光气/甲苯液活化5-氟尿嘧啶,将其以共价键形式键合在高分子上,得5-氟尿嘧啶的高分子前药。用IR、UV、1HNMR及DSC对其结构进行表征,用紫外光谱测定其药物含量,载药高分子的接药率约为38.4%,高分子前药在pH=7.2的磷酸盐介质中42天内的药物累积释放量为57.53%。实验结果表明,5-氟尿嘧啶以共价键的形式键合在聚[N-(2-羟乙基)-L-谷酰胺]之上,在体外有明显的缓释效果。     

在水-四氢呋喃中纤维素转化为5-羟甲基糠醛及副产物鉴定

在酸性条件下,水-四氢呋喃混合溶剂中转化纤维素制备了平台化合物5-羟甲基糠醛（HMF）．在纤维素浓度仅为2.4wt%时,可以得到38.6%的HMF,但是随着纤维素浓度的增加,胡敏素和乙酰丙酸成为主要产物．利用液相色谱-多级串联质谱联用技术检测到了分子式为C9H16O4、 C10H14O4、 C11H12O4、C12H10O5 和C12H16O8的一系列副产物．C9H16O4是通过四氢呋喃开环为1,4-丁二醇再与乙酰丙酸酯化反应得到,而C10H14O4是通过四氢呋喃开环后与HMF醚化得到．C11H12O4是由5-羟甲基糠醛与乙酰丙酸发生酯化反应得到,C12H10O5是由HMF自身醚化得到,而C12H16O8是HMF与葡萄糖经过缩醛反应得到．HMF的自身醚化反应及HMF与1,4-丁二醇的醚化反应是主要的副反应．     

Chondroitin/polypyrrole nanocomposite hydrogels for the accurate release of 5-fluorouracil by electrical stimulation

The development of electro-stimulated drug release devices is an innovative approach to attain the drug delivery in accurate doses at target sites in a programmed manner. In this work, novel electroactive nanocomposite hydrogels were prepared by encapsulating green-synthesized polypyrrole (PPy) colloids within chondroitin sulfate (CS) networks during the self-crosslinking of CS via N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide chemistry. The structural and morphological properties of CS/PPy hydrogels were studied by Fourier-transformed infrared spectroscopy, scanning electron microscopy, and swelling kinetic measurements. The chemotherapeutic agent 5-fluorouracil (5-FU) was loaded into CS/PPy samples by hydrogel swelling method, or alternatively, by pre-incubating the drug in polymer mixture before crosslinking. Different electrical stimulations can be used to switch ON and accurately tune the 5-FU delivery from GG/PPy hydrogels. A single pulse potential of 5 V switched on the drug delivery up to 90% from nanocomposite hydrogel, in contrast to the low 5-FU amount released in a passive form (< 20%). PPy electroactive behavior played a determining role as the main driving force in 5-FU release activation. Cytotoxicity of hydrogels with and without 5-FU was examined in normal and cancer cells. Considering the high cytotoxicity of 5-FU, the ON/OFF 5-FU release patterns evidenced the potential of CS/PPy hydrogels for electrically controlled drug delivery in implantable or transdermal drug release devices.     

Controlled release of drug via tuning electrospun polymer carrier

Medicated‐fibers have been obtained through electrospinning after rifampin was dissolved in poly (lactic acid)/chloroform solution. The relationship between polymer variables [such as concentration, molecular weight (M_w), and introducing hydrophilic block] and drug release from the electrospun fibers is disclosed. The results show that polymeric concentration and M_w are crucial for producing the medicated fibers, which influence not only the morphology of the medicated‐fiber but also drug release rate from fiber. At the same M_w, the drug release rate decreases with the increase of spinning concentration. At two different M_w blends, drug release behaviors change. When the low M_w content is in a dominant position, drug release rate depends largely on mixing ratio of two M_w contents; on the other hand, drug release rate is also dependent on concentration of spinning fluid. In addition, the block copolymer [poly‐L ‐lactic acid (PLLA)‐polyethylene glycol‐PLLA] shows faster release rate as compared to homopolymer (PLLA). © 2011 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys, 2011     

Preparation and drug release behavior of temperature-responsive mesoporous carbons

A temperature-responsive composite based on poly (N-isopropylacrylamide) (PNIPAAm) and ordered mesoporous carbons (OMCs) has been successfully prepared by a simple wetness impregnation technique. The structures and properties of the composite were characterized by infrared spectroscopy (IR), X-ray diffraction (XRD), transmission electron microscopy (TEM), N₂ sorption, thermogravimetric analysis (TG) and differential scanning calorimetry (DSC). The results showed that the inclusion of PNIPAAm had not greatly changed the basic ordered pore structure of the OMCs. Ibuprofen (IBU) was selected as model drug, and in vitro test of IBU release exhibited a temperature-responsive controlled release delivery.     

杂原子介孔Ce-MCM-41分子筛的制备及其吸附脱除甲硫醚性能

以十六烷基三甲基溴化铵为模板剂,正硅酸乙酯(TEOS)为硅源,硝酸铈为铈源,采用水热法合成了杂原子介孔分子筛Ce-MCM-41。XRD和FT-IR表征结果表明,当加入的Ce/Si物质的量比小于0.04时合成了规整有序的介孔结构,并将Ce原子引入到MCM-41骨架中。N₂吸附-脱附测试获得MCM-41和Ce-MCM-41(Ce/Si物质的量比为0.04)的平均孔径分别为2.82和2.46 nm,孔容分别为0.762 1和 0.689 4 m³/g,BET比表面积分别为986.42和756.8 m²/g。NH₃-TPD表征结果表明,Ce-MCM-41的酸性要明显强于MCM-41,但两种分子筛的酸性均较弱。利用合成的MCM-41和Ce-MCM-41吸附脱除甲硫醚浓度为58 μg(甲硫醚)/g的甲硫醚/氮气混合气中的甲硫醚。甲硫醚分子尺寸的模拟结果为0.464 8 nm,可以很容易地进入分子筛的介孔孔道中。由于Ce-MCM-41分子筛具有较多的酸量,其硫吸附容量7.52 mg(S)/g明显高于MCM-41的4.57 mg(S)/g。MCM-41和Ce-MCM-41都具有较好的再生性能,再生3次后硫吸附容量仍可恢复到初始容量的80%,分别为3.52和 5.86 mg(S)/g。     

5-氟尿嘧啶/壳聚糖载药纳米微球的制备及性能

以三聚磷酸钠为交联剂,采用离子交联法制备了5-氟尿嘧啶/壳聚糖纳米微球,评价其性能、体外释药性能及对人肺癌细胞GLC-82的体外杀伤效应,并通过Zeta电位和红外光谱分析载药纳米微球形成机理.结果表明,所制备的5-Fu/CS纳米微球平均包封率为32.3%,平均载药量为25.6%,平均粒径为253nm,平均zeta电势为+8.38mV,成球性及分散性良好.CS载药纳米微球具有缓释性能,体外释药行为符合双向动力学规律.在体外作用72h,CS载药纳米微球对人肺癌细胞GLC-82的杀伤率达66.6%,杀伤效果明显优于5-Fu对照组.     

Physicochemical and catalytic properties of CoAPO-5 and CoAPSO-5 molecular sieves

The physicochemical and catalytic properties of cobalt- and silicon-substituted AlPO-5 molecular sieves were studied by means of temperature-programmed reduction, temperature-programmed desorption of ammonia and the reaction of toluene disproportionation.     

Syntheses and antitumor activities of medium molecular weight polymers containing 5-fluorouracil

The new monomer α-ethoxy-3,6-endo-methylene-1,2,3,6-tetrahydrophthaloyl-5-fluorouracil (EMTFU) was synthesized from 5-fluorouracil (5-FU) and α-ethoxy-3,6-endo-methylene-1,2,3,6-tetrahydrophthaloyl chloride (EMTC). Poly(α-ethoxy-3,6-endomethylene-1,2,3,6-tetrahydrophthaloyl-5-fluorouracil) [poly(EMTFU)], poly(α-ethoxy-3,6-endo-methylene-1,2,3,6-tetrahydrophthaloyl-5-fluorouracil-co-acrylic acid) [poly(EMTFU-co-AA)], and poly(α-ethoxy-3,6-endomethylene-1,2,3,6-tetrahydrophthaloyl-5-fluorouracil-co-vinyl acetate) [poly(EMTFU-co-VAc)] were synthesized by photopolymerizations using 2,2-dimethoxy-2-phenylacetophenone (DMP) as the photoinitiator. The synthesized EMTFU and its polymers were identified by Fourier transfer infrared (FT-IR), ¹H nuclear magnetic resonance (NMR), and ¹³C-NMR spectroscopies. The contents of EMTFU in poly(EMTFU-co-AA) and poly(EMTFU-co-VAc) determined by elemental analysis were 46 and 70 mol %, respectively. The number average molecular weights of the synthesized polymers determined by gel permeation chromatography (GPC) were in range of 17,200–20,900. The in vitro cytotoxicities of samples were evaluated with mouse mammary carcinoma (FM3A), mouse leukemia (P388), and human histiocytic lymphoma (U937) as cancer cell lines and AC2F as a normal cell line. The cytotoxicities of 5-FU and synthesized samples against cancer cell lines increased in following orders: 5-FU ≈ EMTFU > poly(EMTFU-co-AA) > poly(EMTFU) > poly(EMTFU-co-VAc). The in vivo antitumor activities of the synthesized samples against mice bearing the sarcoma 180 tumor cell line were evaluated. The in vivo antitumor activities of EMTFU and its polymers were greater than those of 5-FU at a dosage of 80 mg/kg. © 1998 John Wiley & Sons, Inc. J Polym Sci A: Polym Chem 36: 2985–2992, 1998     

A theoretical study on the pure and doped ZnO nanoclusters as effective nanobiosensors for 5-fluorouracil anticancer drug adsorption

The electronic sensitivity and effectiveness of the pristine, Fe,- Mg-, Al- and Ga-doped ZnO nanoclusters interacted with 5-fluorouracil (5-FU) anticancer drug are theoretically investigated in the gas phase using the B3LYP/wB97XD density functional theory calculations with LANL2DZ basis set. It is concluded that 5-FU adsorption on the doped nanoclusters has relatively higher adsorption energy as compared with the pristine zinc oxide. A number of thermodynamic parameters, such as band gap energy (E_g), adsorption energy (E_ad), molecular electrostatic potential, global hardness (η) and density of electronic states, are attained and compared. Also, calculated geometrical parameters and electronic properties for the studied systems indicate that Mg- and Ga-doped Zn₁₂O₁₂ present higher sensitivity to 5-FU compared with the pristine nanocluster. Theoretical results reveal that adsorption of 5-FU on the doped nanoclusters is influenced by the electronic conductance of the nanocluster. Therefore, Mg- and Ga-doped ZnO can be considered as promising nanobiosensors for detection of 5-FU in medicine.     

麦饭石含量对载药复合凝胶小球释药性能的影响

以瓜尔胶-g-聚丙烯酸/麦饭石复合水凝胶(GG-g-PAA/MS)和海藻酸钠(SA)为原料,双氯芬酸钠(DS)为模拟药物,采用离子凝胶法制备了载药复合凝胶小球,考察了pH敏感性以及MS含量对复合凝胶小球的包封率、载药率、溶胀性和药物释放行为的影响.结果表明:凝胶小球具有明显的pH敏感性,在不同pH介质中溶胀率和释放速率...     

Issues in the synthesis of crystalline molecular sieves: towards the crystallization of low framework-density structures.

Fundamental and practical interest in crystalline, microporous, molecular sieves is largely a direct consequence of the fact that their bulk properties can be manipulated through variations in atomic structure. This correspondence between the macroscale and the atomic scale is due to the uniformity of these crystalline materials. Control of the atomic structure therefore is of extreme importance, and is the thesis of this Review. Synthesis mechanisms and the parameters that can direct the crystal assembly pathway and the ultimate product formed are discussed and rationalized.